OncoImmune, Inc.

Merck & Co is in advanced discussions with Seagen about a possible takeover bid, according to the Wall Street Journal , but sources close to talks have said a deal is not yet imminent. The newspap

Phase III data on Merck & Co., Inc. and Ridgeback Biotherapeutics LP 's oral ribonucleoside analog molnupiravir are being hailed as a transformative event for the COVID-19 pandemic, since an oral a

Cerevel CEO Coles On Post-COVID Opportunities The COVID-19 pandemic changed the conversation about the biopharma industry from pricing, reimbursement and affordability to “how could we save the world,

Cerevel CEO Coles On Post-COVID Opportunities The COVID-19 pandemic changed the conversation about the biopharma industry from pricing, reimbursement and affordability to “how could we save the world,